Tag: Pfizer
Pfizer, Johnson & Johnson Settle Remicade Antitrust Suit
Pfizer settled with Johnson & Johnson, ending a four-year battle over J&J’s alleged use of exclusionary contracts to block biosimilar competition to its immunosuppressive...
Pfizer Pays To Exit EpiPen Price-Gouging Case
Pfizer and two subsidiaries will pay $345 million to escape antitrust litigation over an alleged scheme to gouge purchasers of the EpiPen, a lifesaving...
Request To Create California Subclass In Lipitor Antitrust Case Refused
A federal judge has refused to create a California subclass within a nationwide proposed class action accusing Pfizer of obtaining a fraudulent patent and...
Pfizer To Grow COVID-19 Vaccine Production With Sanofi Deal
Sanofi has agreed to produce millions of doses of BioNTech and Pfizer’s coronavirus vaccine in an unusual collaboration to speed vaccination efforts, reported Bloomberg.
The...
FTC Imposes Conditions On Pfizer’s Upjohn & Mylan Deal
Pharmaceutical companies Pfizer and Mylan have agreed to divest assets and abide by other conditions to settle Federal Trade Commission (FTC) charges that the...
Refusals to License Patents under Australia’s “New” Unilateral Conduct Prohibition
By Arlen Duke & Rhonda L. Smith (University of Melbourne)*
Both intellectual property (“IP”) and competition policies aim to provide an incentive for creation/innovation. However,...
UK’s CMA Told To Review Evidence Against Pfizer And Flynn
Britain’s competition regulator has been told to review its evidence against US drugmaker Pfizer and Flynn Pharma in the UK as it seeks to...
UK: Watchdog seeks to reinstate fine against Pfizer and Flynn
The UK’s competition regulator is trying to reinstate a record £90 million (US$116.2 million) fine against drug companies Pfizer and Flynn for raising the...
US: Pfizer and Mylan reportedly near merger deal for low-priced drugs
Pfizer plans to combine its off-patent business, which includes Lipitor cholesterol pills and male-impotence drug Viagra, with Mylan NV and form a generic drug...
EU: GSK offers concessions over Pfizer deal
According to Reuters, GlaxoSmithKline has offered concessions to address EU antitrust concerns over its planned joint venture with Pfizer’s consumer health business, the European Commission...
